SCHEMBL24401007

SCHEMBL24401007

O=C(O)c1ccc2c(c1)C(F)(F)CC2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 4/20 0.58
KDM4E B2RXH2 2/20 0.51
MAPT P10636 2/20 0.51
ALDH1A1 P00352 2/20 0.51
POLB P06746 1/20 0.51
BLM P54132 1/20 0.51
GRM1 Q13255 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
MEN1 O00255 1/20 0.51
MAPK1 P28482 1/20 0.51
CYP2C19 P33261 1/20 0.51
KMT2A Q03164 1/20 0.51
RARB P10826 5/20 0.42
RARG P13631 4/20 0.42
RARA P10276 3/20 0.42
CYP26A1 O43174 1/20 0.42
CYP26B1 Q9NR63 1/20 0.42
RXRA P19793 3/20 0.42
RXRB P28702 1/20 0.41
RXRG P48443 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24400674 0.88 KDM4E (0.62) KDM1AKDM4EMAPTALDH1A1POLB
SCHEMBL24401017 0.80 PDK2 (0.48) KDM1AKDM4EMAPTALDH1A1TDP1
SCHEMBL7400117 0.76 KDM4E (0.79) KDM1AKDM4EMAPTALDH1A1POLB
SCHEMBL30831515 0.76 KDM1A (0.55) KDM1AKDM4EMAPTALDH1A1POLB
SCHEMBL23706010 0.73 KDM1A (0.52) KDM1AKDM4EMAPTALDH1A1POLB
SCHEMBL17987986 0.73 KDM1A (1.00) KDM1AKDM4EMAPTALDH1A1POLB
SCHEMBL19764448 0.73 KDM1A (0.73) KDM1AKDM4EMAPTALDH1A1POLB
SCHEMBL23705938 0.73 KDM1A (0.52) KDM1AKDM4EMAPTALDH1A1POLB
SCHEMBL23706158 0.73 KDM1A (0.52) KDM1AKDM4EMAPTALDH1A1POLB
SCHEMBL30097044 0.73 KDM1A (0.52) KDM1AKDM4EMAPTALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220135539-A1 BIARYL AMIDE COMPOUNDS, PREPARATION METHODS AND MEDICAL APPLICATIONS THEREOF Eternity Bioscience Inc. 2022-05-05 US disclosed
US-20220135539-A1 BIARYL AMIDE COMPOUNDS, PREPARATION METHODS AND MEDICAL APPLICATIONS THEREOF Eternity Bioscience Inc. 2022-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220135539-A1 BIARYL AMIDE COMPOUNDS, PREPARATION METHODS AND MEDICAL APPLICATIONS THEREOF BRAF, NRAS, RAF1 KDM1A 3057/4885KDM4E 2984/4885MAPT 4504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.